Severe Asthma and Biological Therapy: When, Which, and for Whom

Asthma is a heterogeneous chronic inflammatory disease of the airways that affects approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from severe or uncontrolled asthma, associated with increased mortality and hospitalization, reduced quality of life, and increased heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogliani, Paola, Calzetta, Luigino, Matera, Maria Gabriella, Laitano, Rossella, Ritondo, Beatrice Ludovica, Hanania, Nicola A., Cazzola, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229123/
https://www.ncbi.nlm.nih.gov/pubmed/32048241
http://dx.doi.org/10.1007/s41030-019-00109-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229123/
https://www.ncbi.nlm.nih.gov/pubmed/32048241
http://dx.doi.org/10.1007/s41030-019-00109-1

Ejemplares similares